Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pucotenlimab + CAPEOX + Low-Dose Radiotherapy in pMMR/MSS Locally Advanced Rectal Adenocarcinoma
NCT07448142Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Mar 2026
- Primary completion
- Sep 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of pucotenlimab in rectal adenocarcinoma, sponsored by Sun Yat-sen University. Started Mar 2026; status: recruiting.
02
Drugs
pucotenlimab
03
Conditions
rectal adenocarcinoma
Beyond the preview
Go deeper on NCT07448142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07448142.